140 related articles for article (PubMed ID: 8334680)
1. Cytokine production in whole blood cell cultures of patients undergoing therapy with biological response modifiers or 5-fluorouracil.
Elsässer-Beile U; von Kleist S; Lindenthal A; Birken R; Gallati H; Mönting JS
Cancer Immunol Immunother; 1993 Aug; 37(3):169-74. PubMed ID: 8334680
[TBL] [Abstract][Full Text] [Related]
2. Correlation of clinical and immunological parameters of metastatic renal cell carcinoma patients undergoing therapy with interleukin 2, interferon-alpha and retinoic acid.
Elsässer-Beile U; Kölble N; Grussenmeyer T; Wetterauer U; Schultze-Seemann W
Anticancer Res; 1998; 18(3B):1883-90. PubMed ID: 9677439
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a test system for measuring cytokine production in human whole blood cell cultures.
Elsässer-Beile U; von Kleist S; Gallati H
J Immunol Methods; 1991 Jun; 139(2):191-5. PubMed ID: 1904464
[TBL] [Abstract][Full Text] [Related]
4. Circulating cytokines in patients with metastatic cancer treated with recombinant interleukin 2 and lymphokine-activated killer cells.
Gemlo BT; Palladino MA; Jaffe HS; Espevik TP; Rayner AA
Cancer Res; 1988 Oct; 48(20):5864-7. PubMed ID: 3139285
[TBL] [Abstract][Full Text] [Related]
5. Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.
Alvarado Esquivel C; Elewaut A; Philippé J; Elewaut AE; Desombere I; Maertens G; Leroux-Roels G
Rev Invest Clin; 2002; 54(1):41-50. PubMed ID: 11995406
[TBL] [Abstract][Full Text] [Related]
6. In vivo induction of gamma interferon and tumor necrosis factor by interleukin-2 infusion following intensive chemotherapy or autologous marrow transplantation.
Heslop HE; Gottlieb DJ; Bianchi AC; Meager A; Prentice HG; Mehta AB; Hoffbrand AV; Brenner MK
Blood; 1989 Sep; 74(4):1374-80. PubMed ID: 2504308
[TBL] [Abstract][Full Text] [Related]
7. Impaired cytokine production in whole blood cell cultures of patients with gynaecological carcinomas in different clinical stages.
Elsässer-Beile U; von Kleist S; Sauther W; Gallati H; Mönting JS
Br J Cancer; 1993 Jul; 68(1):32-6. PubMed ID: 8318418
[TBL] [Abstract][Full Text] [Related]
8. Cytokine production from murine CD4 and CD8 cells after mannan-MUC1 immunization.
Lees CJ; Apostolopoulos V; McKenzie IF
J Interferon Cytokine Res; 1999 Dec; 19(12):1373-9. PubMed ID: 10638706
[TBL] [Abstract][Full Text] [Related]
9. A pilot study of gamma-1b-interferon in combination with fluorouracil, leucovorin, and alpha-2a-interferon.
Grem JL; McAtee N; Murphy RF; Balis FM; Cullen E; Chen AP; Hamilton JM; Steinberg SM; Quinn M; Sorensen JM; Arbuck SG; Lawrence D; Pang J; Allegra CJ
Clin Cancer Res; 1997 Jul; 3(7):1125-34. PubMed ID: 9815792
[TBL] [Abstract][Full Text] [Related]
10. Activation of cytokine production and adhesion molecule expression on THP-1 myelomonocytic cells by macrophage colony-stimulating factor in combination with interferon-gamma.
Kimball ES; Kovacs E; Clark MC; Schneider CR
J Leukoc Biol; 1995 Nov; 58(5):585-94. PubMed ID: 7595061
[TBL] [Abstract][Full Text] [Related]
11. Cytokine production by T-cell lines derived from tumor-infiltrating lymphocytes from patients with ovarian carcinoma: tumor-specific immune responses and inhibition of antigen-independent cytokine production by ovarian tumor cells.
Kooi S; Freedman RS; Rodriguez-Villanueva J; Platsoucas CD
Lymphokine Cytokine Res; 1993 Dec; 12(6):429-37. PubMed ID: 8123759
[TBL] [Abstract][Full Text] [Related]
12. Modulating effect of interleukin 2 therapy on interferon production by blood leukocytes of patients with minimal residual hematological disease.
Kandefer-Szerszeń M; Legieć W; Dmoszyńska A; Szuster-Ciesielska A
Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):177-81. PubMed ID: 9597084
[TBL] [Abstract][Full Text] [Related]
13. The effect of Edrecolomab (Mo17-1A) or fluorouracil-based chemotherapy on specific immune parameters in patients with colorectal cancer. A comparative study.
Tsavaris NB; Katsoulas HL; Kosmas C; Papalambros E; Gouveris P; Papantoniou N; Rokana S; Kosmas N; Skopeliti M; Tsitsilonis OE
Oncology; 2004; 67(5-6):403-10. PubMed ID: 15713997
[TBL] [Abstract][Full Text] [Related]
14. Effects of natural eggshell membrane (NEM) on cytokine production in cultures of peripheral blood mononuclear cells: increased suppression of tumor necrosis factor-α levels after in vitro digestion.
Benson KF; Ruff KJ; Jensen GS
J Med Food; 2012 Apr; 15(4):360-8. PubMed ID: 22168811
[TBL] [Abstract][Full Text] [Related]
15. Generation of monocyte-derived dendritic cells from patients with renal cell cancer: modulation of their functional properties after therapy with biological response modifiers (IFN-alpha plus IL-2 and IL-12).
Merad M; Angevin E; Wolfers J; Flament C; Lorenzi I; Triebel F; Escudier B; Zitvogel L
J Immunother; 2000; 23(3):369-78. PubMed ID: 10838666
[TBL] [Abstract][Full Text] [Related]
16. Selective suppression of cytokine secretion in patients with small-cell lung cancer.
Fischer JR; Schindel M; Stein N; Lahm H; Gallati H; Krammer PH; Drings P
Ann Oncol; 1995 Nov; 6(9):921-6. PubMed ID: 8624296
[TBL] [Abstract][Full Text] [Related]
17. Cytokine regulation of human monocyte interleukin-1 (IL-1) production in vitro. Enhancement of IL-1 production by interferon (IFN) gamma, tumour necrosis factor-alpha, IL-2 and IL-1, and inhibition by IFN-alpha.
Danis VA; Kulesz AJ; Nelson DS; Brooks PM
Clin Exp Immunol; 1990 Jun; 80(3):435-43. PubMed ID: 2115419
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneous response of human colon cancer cells to the cytostatic and cytotoxic effects of recombinant human cytokines: interferon-alpha, interferon-gamma, tumor necrosis factor, and interleukin-1.
Morikawa K; Fidler IJ
J Biol Response Mod; 1989 Apr; 8(2):206-18. PubMed ID: 2499665
[TBL] [Abstract][Full Text] [Related]
19. Investigation of serum cytokine levels and cytokine production in whole blood cultures of paranoid schizophrenic patients.
Kamińska T; Wysocka A; Marmurowska-Michalowska H; Dubas-Slemp H; Kandefer-Szerszeń M
Arch Immunol Ther Exp (Warsz); 2001; 49(6):439-45. PubMed ID: 11814238
[TBL] [Abstract][Full Text] [Related]
20. Effects of granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-2, interferon-gamma (IFN-gamma), tumour necrosis factor-alpha (TNF-alpha) and IL-6 on the production of immunoreactive IL-1 and TNF-alpha by human monocytes.
Danis VA; Franic GM; Rathjen DA; Brooks PM
Clin Exp Immunol; 1991 Jul; 85(1):143-50. PubMed ID: 1906383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
